Global Bio Pharma Buffer Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

A buffer solution is comprised of a weak conjugate acid-base pair, for example, a weak acid and its conjugate base, or a weak base and its conjugate acid. Small quantities of other acids or bases are neutralized when added to the solution, and as a result, the solution resists changes in pH. Solutions with stable pH are required for the processing of protein-based biologic APIs because of their sensitivity to changes in pH. The stable pH range and capacity (the amount of acid/base that can be added without a change in pH) of a buffer are determined by the conjugate acid-base pair.
Most purification steps for downstream processing of biologics require buffers to equilibrate, condition, wash, elute, or concentrate the product. They are used in product isolation and purification steps to facilitate protein capture and polishing and also in the filtration process for the removal of viruses or depyrogenation. Aqueous solutions are also required for cleaning and disinfecting downstream processing equipment, such as chromatography matrices and membrane filtration systems. The main equipment involved in downstream processing with buffers includes mixers for buffer preparation, as well as equipment for purification, including packed-bed chromatography systems, fluidized beds, ultrafiltration and diafiltration membranes, microfiltration membranes, depth filtration cartridges, and virus-removal systems.
According to our (Global Info Research) latest study, the global Bio Pharma Buffer market size was valued at USD 865.8 million in 2022 and is forecast to a readjusted size of USD 1380.3 million by 2029 with a CAGR of 6.9% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The key players are Avantor, Alfa Aesar (Thermo Fisher), Merck, Lonza, Bio-Rad, BD, GE, Healthcare, Promega Corporation, Hamilton Company, XZL BIO-TECHNOLOGY, SRL and so on. According to the revenue of these companies, we can know that the Bio Pharma Buffer industry is relative concentrated. Because the top 6 companies have more than 70% market share.
This report is a detailed and comprehensive analysis for global Bio Pharma Buffer market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Bio Pharma Buffer market size and forecasts, in consumption value ($ Million), sales quantity (K Liter), and average selling prices (USD/Liter), 2018-2029
Global Bio Pharma Buffer market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Liter), and average selling prices (USD/Liter), 2018-2029
Global Bio Pharma Buffer market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Liter), and average selling prices (USD/Liter), 2018-2029
Global Bio Pharma Buffer market shares of main players, shipments in revenue ($ Million), sales quantity (K Liter), and ASP (USD/Liter), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Bio Pharma Buffer
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Bio Pharma Buffer market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Avantor, Alfa Aesar (Thermo Fisher), Merck, Lonza and Bio-Rad, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Bio Pharma Buffer market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
    Phosphates Type
    Acetates Type
    TRIS Type
    Others
Market segment by Application
    Research Institution
    Pharmaceutical Industry
    Others
Major players covered
    Avantor
    Alfa Aesar (Thermo Fisher)
    Merck
    Lonza
    Bio-Rad
    BD
    GE Healthcare
    Promega Corporation
    Hamilton Company
    XZL BIO-TECHNOLOGY
    SRL
Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Bio Pharma Buffer product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Bio Pharma Buffer, with price, sales, revenue and global market share of Bio Pharma Buffer from 2018 to 2023.
Chapter 3, the Bio Pharma Buffer competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Bio Pharma Buffer breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Bio Pharma Buffer market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Bio Pharma Buffer.
Chapter 14 and 15, to describe Bio Pharma Buffer sales channel, distributors, customers, research findings and conclusion.